Nanocellulose-based Synergistic Systems for Advanced Healthcare
Legal Citation
Summary of the Inventive Concept
This inventive concept integrates nanocellulose-derived hydrogels with distinct technologies, such as AI, IoT, blockchain, and novel materials, to create powerful systems for personalized diabetes management, real-time protein stability monitoring, secure pharmaceutical supply chain management, customized oral drug delivery, and optimized protein loading and sustained release.
Background and Problem Solved
The original patent, 'Nanocellulose as an embedding matrix and applications thereof,' provided a versatile nanocellulose-derived hydrogel drug delivery system for oral dosing pharmaceuticals. However, it had limitations in terms of scalability, monitoring, and security. The new inventive concept addresses these limitations by synergistically combining nanocellulose with other technologies to create more advanced and efficient systems.
Detailed Description of the Inventive Concept
The new claims encompass five distinct systems: (1) a personalized diabetes management system integrating nanocellulose-based oral insulin delivery with an AI-powered health monitoring platform, (2) an IoT-enabled real-time protein stability monitoring method for nanocellulose-derived hydrogels, (3) a blockchain-based secure data management system for tracking nanocellulose-based pharmaceuticals, (4) a novel nanocellulose-polymer composite material for 3D printing customized oral drug delivery devices, and (5) a synergistic combination of nanocellulose-based hydrogels with graphene oxide for enhanced protein loading and sustained release. These systems leverage the benefits of nanocellulose while addressing the limitations of the original patent.
Novelty and Inventive Step
The new claims introduce novel synergistic combinations of nanocellulose with distinct technologies, providing a non-obvious and innovative approach to advanced healthcare systems. The integration of AI, IoT, blockchain, and novel materials with nanocellulose-derived hydrogels creates a new paradigm for efficient, secure, and personalized healthcare solutions.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the integration of nanocellulose with other emerging technologies, such as quantum computing or synthetic biology, to further enhance the capabilities of the systems. Additionally, variations of the systems could be developed for specific therapeutic applications or disease management.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the healthcare industry, particularly in the areas of diabetes management, pharmaceutical development, and personalized medicine. The target market includes pharmaceutical companies, healthcare providers, and medical device manufacturers seeking to develop and integrate advanced healthcare systems.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K47/38 |
| A | A61 | A61K47/40 |
| A | A61 | A61L27/20 |
| A | A61 | A61L27/52 |
| B | B82 | B82Y5/00 |
| B | B82 | B82Y30/00 |
| B | B82 | B82Y40/00 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical drug delivery systems, nanomaterials, and biomedical engineering, with expertise in hydrogel technologies, nanocellulose-based drug encapsulation, and advanced material design for controlled drug release
Person of Ordinary Skill (PHOSITA) Profile
A researcher or engineer with advanced degrees in materials science, chemical engineering, or biomedical engineering, possessing knowledge of nanocellulose properties, drug delivery mechanisms, and emerging technologies for pharmaceutical formulations
Obviousness Rationale
A PHOSITA would recognize that the PTD's variations represent predictable extensions of the source patent's nanocellulose hydrogel drug delivery system by integrating known technologies and materials to enhance drug delivery, monitoring, and pharmaceutical management. The disclosed combinations leverage standard techniques in materials science and pharmaceutical engineering to address known limitations in drug delivery technologies. The synergistic approaches demonstrate incremental improvements that would be apparent to a skilled practitioner familiar with nanocellulose drug delivery systems.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,632 |
|---|---|
| Title | Nanocellulose as an embedding matrix and applications thereof |
| Assignee(s) | INNOSENSE LLC |